Skip to search formSkip to main contentSkip to account menu

halobetasol

Known as: Ulobetasol, halobetasol [Chemical/Ingredient], Ulobétasol 
A synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictor activities. Halobetasol, a topical steroid, diffuses across cell… 
National Institutes of Health

Related topics

Related topics

16 relations

Broader (2)

ClobetasolVasoconstrictor Agents
Decreased Protein Synthesis [PE]Facial DermatosesFoot DermatosesGlucocorticoid Receptor Agonists [MoA]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis…
Abstract Background: The fixed-dose combination foam formulation of calcipotriene 0.005% plus betamethasone dipropionate 0.064… 
2019
2019
Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential.
Background: Psoriasis is a chronic inflammatory skin disorder often managed with topical therapy. However, the most widely used… 
2014
2014
An investigator-initiated, double-blind, vehicle-controlled pilot study: assessment for tachyphylaxis to topically occluded halobetasol 0.05% ointment in the treatment of psoriasis.
2011
2011
Comparative study of halobetasol and tacrolimus in treatment of Lichen Planus.
INTRODUCTION : Lichen Planus is one of the most itchy dermatoses. It is prevalent worldwide with no social or climatic… 
2008
2008
Follow-Up Is Key in Vulvovaginal Lichen Planus
2005
2005
Ulobetasol generic launched in the US
  • 2005
  • Corpus ID: 195162990
1996
1996
Interferon alfa-induced interstitial pneumonitis in a patient with cutaneous T-cell lymphoma.
Review
1992
Review
1992
A cost-comparison study: Ulobetasol versus clobetasol in severe localized psoriasis.
A computerized decision-tree model was used in a cost-comparison study of two ultra-high potency topical corticosteroids… 
1990
1990
Treatment of Localized Vitiligo with Ulobetasol Cream
V itiligo is a common depigmentary skin disorder of uncertain etiology, prevalent in 1-2% of the general population. An… 
1990
1990
The Safety of Halobetasol 0.05% Ointment in the Treatment of Psoriasis
The effects on the hypothalamic‐pituitary‐adrenal axis of the ultra‐high potency corticosteroid halobetasol in the treatment of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)